Form 4: RxSight CFO Shelley Thunen Sells Shares Under 10b5-1 Trading Plan

Shelley Thunen, CFO of RxSight, Inc., executed multiple sales of common stock on April 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Shelley Thunen, the Chief Financial Officer of RxSight, Inc. (RXST), reported the sale of company common stock on April 1, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 14, 2023.
• Multiple transactions occurred at varying prices, with weighted average prices reported for each set of sales.
• Thunen sold a total of 19,990 shares directly.
• After the reported transactions, Thunen directly owns 13,691 shares and indirectly owns 8,402 shares through a family trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan, which is a common practice.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The market will likely interpret this as a neutral event unless the volume of sales is unusually high or coincides with other negative news.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates